Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

<h3>Background</h3><p dir="ltr">Triple-Negative Breast Cancer (TNBC) is a lethal subtype of breast cancer with limited treatment options. The purpose of this Network Meta-Analysis (NMA) is to compare the efficacy and safety of inhibitors of programmed cell death 1 (PD-1)...

Full description

Saved in:
Bibliographic Details
Main Author: Ibrahim Elmakaty (14614270) (author)
Other Authors: Ruba Abdo (15455318) (author), Ahmed Elsabagh (15455321) (author), Abdelrahman Elsayed (6288913) (author), Mohammed Imad Malki (9649555) (author)
Published: 2023
Subjects:
Biological sciences
Genetics
Biomedical and clinical sciences
Oncology and carcinogenesis
PD-1/PD-L1 inhibitors
Immune checkpoint inhibitors
Overall survival
Progression-free survival
Pathological complete response
Adverse events
Efcacy
Safety
Systematic review
Network meta-analysis
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items